59 results on '"Massie, Barry M."'
Search Results
2. Medical Resource Use, Costs, and Quality of Life in Patients With Acute Decompensated Heart Failure: Findings From ASCEND-HF
3. Clinical Pharmacy Services in Heart Failure: An Opinion Paper From the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network
4. The Heart Failure Society of America in 2020: A Vision for the Future
5. ACCF/AHA/HFSA 2011 Survey Results: Current Staffing Profile of Heart Failure Programs, Including Programs That Perform Heart Transplant and Mechanical Circulatory Support Device Implantation
6. Guidelines, Performance Measures, and the Practice of Medicine: Mind the Gap
7. Resource Use and Costs of Treatment With Anticoagulation and Antiplatelet Agents: Results of the WATCH Trial Economic Evaluation
8. The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A 1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment
9. The Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial: Rationale and Design
10. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study
11. The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics
12. Risk stratification after hospitalization for decompensated heart failure
13. A comparative analysis of the results from 4 trials of β-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS
14. Failure of benefit and early hazard of bucindolol for Class IV heart failure
15. Aligning quality and payment for heart failure care: Defining the challenges
16. Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION
17. Negative, neutral, and discordant results: What should an editor do?
18. Beware the rising creatinine level
19. What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians
20. The prognostic importance of different definitions of worsening renal function in congestive heart failure
21. Treating heart failure: It's time for new paradigms and novel approaches
22. Journal of Cardiac Failure: The next phase
23. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals
24. Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE)
25. Silent Cerebral Infarction in Heart Failure: Vascular or Thromboembolic?
26. What is the significance of a journal's impact factor?
27. LVADs as long-term cardiac replacement: Success but on what terms and at what cost?
28. Remodeling the Journal of Cardiac Failure: How can the readership contribute?
29. A personal comment on the 2001 Heart Failure Society of America annual scientific meeting: Defining the character of our organization
30. CTST-21: A Phase 2, Randomized, Double-Blind, Multi-Center Study Comparing 15G Cross-Linked Polyelectrolyte (CLP) versus Placebo in Heart Failure Patients with Chronic Kidney Disease
31. Characteristics of Implantable Cardioverter-defibrillator Recipients for the Primary and Secondary Prevention of Sudden Cardiac Death in the Outcomes Among Veterans With Implantable Defibrillators (OVID) Registry
32. Guidelines are Merely Guidelines
33. Troponin Release in Patients Admitted with Acute Decompensated Heart Failure and Renal Dysfunction: Results from the Pilot Phase of the PROTECT Trial
34. Trends in Heart Failure Hospitalization Rate and Outcome in the United States
35. Effects of the Adenosine A 1 Receptor Antagonist, KW-3902, Alone and in Combination with Furosemide, on Diuresis and Renal Function in Hospitalized Acutely Decompensated Heart Failure Patients with Renal Impairment or Refractory to Maximum Dose of Conventional Diuretics: Two Randomized, Double-Blind, Placebo-Controlled Studies.
36. Relative Predictive Utility of Changes in Weight and Impedance Cardiography-Based Thoracic Fluid Content To Identify Short-Term Risk of Clinical Decompensation in Stable Patients with Chronic Heart Failure
37. Levosimendan Provides Rapid and Sustained Relief in Patient Global Assessment of Acutely Decompensated Heart Failure: The REVIVE II Study
38. Levosimendan Reduces Length of Initial Hospital Stay: The REVIVE II Study
39. Effects of the Adenosine A 1 Receptor Antagonist, KW-3902, Alone and in Combination with Furosemide, on Diuresis and Renal Function in Hospitalized Acutely Decompensated Heart Failure Patients with Renal Impairment: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study
40. The Year in Heart Failure 2005
41. Heart Failure Trials: Are They Becoming Impractical?
42. The year in heart failure: 2004
43. Should the management of heart failure become a new subspecialty?
44. 373 Treatments for acute decompensated heart failure have significant international variations: an analysis of the randomized interventions with tezosentan (RITZ-1) trial
45. Beta-blockade in women with heart failure in the community setting: insights from a large prospective beta-blocker registry
46. 260 The relationship between hypotension and renal dysfunction during tezosentan treatment for acute decompensated heart failure: an analysis of the randomized interventions with tezosentan (RITZ-1) trial
47. 234 An international acute heart failure trial may be more representative of the united states population than united states-based studies: an analysis of the randomized interventions with tezosentan (RITZ-1) trial
48. Oxygen saturation by pulse oximetry is not predictive of changes in patient's self-assessment of dyspnea: a sub-study of the randomized interventions with tezosentan (RITZ-1) trial
49. 2003: The year in heart failure
50. The dilemma of drug development for heart failure: when is the time to initiate large clinical trials?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.